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Previous studies have shown that patients with
intermittent claudication who exercise can increase
their walking distance1-5; however, the mechanism by
which this symptomatic improvement occurs is
unclear. Several factors, including improvement in the
collateral circulation, changes in the local metabolic
efficiency of ischemic tissues, and enhanced cardiovas-
cular function, may be involved.2,3 The effect of long-
term exercise training on patients with intermittent
claudication remains unclear, as does the form of exer-
cise that these patients should be advised to undertake.
To date, few studies have rigorously examined
whether exercise-induced improvements in walking
distance result from a generalized increase in central
cardiovascular function or from more localized physi-
ological changes in the lower limb. This study was
designed to establish whether improving cardiovascu-
lar function with an upper-limb exercise training reg-
imen has a beneficial effect on walking distance in
patients with intermittent claudication. If this were
the case, then the prescription of an upper-limb exer-
cise program would avoid the physical discomfort
associated with lower-limb exercise training. Two
training schemes were devised, an upper-limb and a
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lower-limb program. Recruited patients were ran-
domly assigned to either the upper- or the lower-limb
program. The training schedules were devised to
stimulate an equivalent cardiovascular response (as
measured by means of the heart rate) for both modes
of exercise. This was achieved by precisely controlling
the work rate with calibrated upper- and lower-limb
cycle ergometers. It would not have been possible to
achieve a valid comparison with a group undertaking
structured walking exercise. First, the relationship
between walking speed and heart rate is nonlinear,
rendering an accurate prescription of work rate diffi-
cult. Second, the primary output measurement of this
trial was the ability to walk, and the learning curve
associated with a walking program would make sepa-
ration of any cardiovascular changes impossible.
Previously, investigators have recommended that a
6-month study, in which participants exercised three
times a week, should be used to achieve the maximum
benefit from a training program.1 However, effects
are also achievable in shorter, lower frequency stud-
ies.1 This study tested whether an upper-limb training
program could elicit a change in walking distance. A
6-week program was used, because we were not
attempting to develop an optimized training program
for a claudicant group.
SUBJECTS AND METHODS
Patients. A total of 67 patients (33 to 82 years
old) with stable intermittent claudication were recruit-
ed from the vascular clinic at the Northern General
Hospital NHS Trust, Sheffield, UK. Patients were
excluded from the trial if they had experienced symp-
toms for fewer than 12 months, undergone a revascu-
larization process within the last 12 months, or had
exercise-limiting angina, shortness of breath, or severe
arthritis. The median ankle-brachial pressure index
(ABPI) for all patients was 0.68 (range, 0.6 to 0.75).
The ABPI was taken as the highest index value
observed in the more symptomatic limb. Further
demographic data are included in Table I. This study
was approved by the North Sheffield Local Research
Ethics Committee, and all patients gave their informed
consent before entering the program.
Determination of claudication and maximum
walking distances. The functional capabilities of
the lower limb are typically assessed by using tread-
mill walking distance measurements. However, in
our clinical practice, less than half the patients with
claudication who are referred to us are able to under-
take a standard treadmill test at a walking speed of 4
km.h-1. This is mainly because of their concern about
falling or an inability to cope with the walking speed
required by the test. Because of these difficulties with
the treadmill, patients were examined by means of a
shuttle walk test.6 This test offers the advantages that
it involves walking on flat ground at incrementally
increasing speeds and it can accommodate the simul-
taneous assessment of more than one patient. For
this test, patients walked back and forth, between
Table I. Baseline characteristics of the study groups
Variable Untrained (n = 15) Upper-limb (n = 26) Lower-limb (n = 26) Significance
Sex
Men, % 60 83 83 NSχ
Women, % 40 17 17
Age, years 71 (70 to 77) 68 (63 to 70) 70 (61 to 73) NSΚ
Duration of claudication, months 24 (24 to 36) 24 (18 to 33) 24 (15 to 31) NSΚ
Ankle-brachial pressure index 0.71 (0.61 to 0.79) 0.67 (0.56 to 0.73) 0.64 (0.60 to 0.8) NSΚ
Walking distances
Pain-free, meters 142 (108 to 180) 130 (82 to 220) 147 (120 to 220) NSΚ
Maximum, meters 272 (197 to 342) 267 (188 to 340) 228 (199 to 341) NSΚ
Current angina, % 33 8 15 NSχ
Previous myocardial infarction, % 30 10 15 NSχ
Stroke, % 7 8 8 NSχ
Diabetes mellitus, % 26 25 13 NSχ
Smoking history
Current, % 13 38 42
Previous, % 69 51 41 NSχ
None, % 18 11 17
Hyperlipidemia (cholesterol > 40 46 50 NSχ
6.5 mmol/L), %
Values are median (Q25 to Q75). Group differences were determined with the test indicated (NS, not significant, P > .05; , χ, chi-square;
Κ, Kruskal-Wallis). Current smoking status was confirmed by means of CO analysis (Smokerlyzer, Bedfont, UK). Patients with diabetes
mellitus were taking oral hypoglycemics or insulin.
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two cones spaced 10 m apart on a flat gymnasium
floor. The speed at which the patient walked was con-
trolled by means of a series of audible tones record-
ed on a cassette. The patients began walking on the
first tone, and they aimed to reach the 10-m cone by
the next tone. Patients then turned and returned to
the first cone, and the process was repeated. The
patients generally achieved the correct pace within
three laps (30 m). The initial speed at which the
patients walked was 3 km.h-1, and the interval
between audible tones gradually decreased through-
out the test, resulting in an incremental increase of
0.5 km.h-1 in the required walking speed every
minute. The test was completed when patients could
no longer maintain the required pace. The time and
distance to claudication (CD) and the maximum
walking distance (MWD) were determined. The
shuttle test is a reliable measurement of the MWD in
patients with chronic airways obstruction,6 and we
have found it to have a low (less than 10%) variabili-
ty in CD and MWD measurements in patients with
claudication, as determined from three measure-
ments made on separate days (S.N., unpublished
observations).
Assessment of cardiovascular fitness. The car-
diovascular fitness of all patients was assessed before
and after the training program by using friction-
braked upper-limb and lower-limb cycle ergometry
(881E rehab trainer and 824E cycle ergometer,
Monark, Varberg, Sweden). All patients were famil-
iarized with the testing apparatus before commence-
ment of the study. After a 2 minute warm-up against
no resistance, the workload was increased by 10 W
(upper limb) or 25 W (lower limb) at 3-minute
intervals by increasing the frictional load applied to
the flywheel, while patients maintained a constant
rate of 50 revs.min-1. This process was repeated until
the patient was unable to continue, and the final
outputs from each test were recorded as the maxi-
mum arm power (MAP) and maximum leg power
(MLP). The maximum achieved power was record-
ed as the power at which the patient failed, regard-
less of how long the patient had been exercising at
this power. 
The workload increments applied in each test
reflect the different muscle mass involved in the
cranking action (upper limb versus lower limb), and
these were determined on the basis of a pilot study in
five patients with claudication. Heart rate was mea-
sured during the final minute of each power incre-
ment for each assessment, either manually or by
using a continuous output heart rate monitor (Sports
Tester PE-3000, Polar Electro, Finland). A linear
increase in heart rate occurs with work rate in healthy
individuals, and this was also observed in our
patients. Cardiovascular exercise training produces a
decrease in heart rate at the submaximal work rates,
defined at the preexercise assessment, because of
improved stroke volume.7 The heart rate versus work
rate relationship for incremental arm and leg crank-
ing was examined before and after training to assess
changes in the cardiovascular fitness of the patients.
All patients were assessed by using both the upper-
and lower-limb ergometry protocols, irrespective of
the training program to which they were subsequent-
ly assigned. Tests were performed in random order at
least 1 day apart by an independent observer.
Training programs. After the assessment of
physical work capacity (arm and leg cranking) and
walking distances, each patient was randomly assigned
to either a lower-limb (n = 26) or upper-limb (n = 26)
training group. Supervised exercise training was
undertaken twice a week for 6 weeks. Members of an
additional untrained group (n = 15) were recruited on
an ad hoc basis in parallel with the main trial, by using
identical inclusion criteria. This group was subse-
quently shown to possess a similar demographic dis-
tribution to the exercise groups. Untrained patients
were given lifestyle advice, including encouragement
to undertake regular exercise, but did not undertake
any formal training sessions. This is the advice given
to stable patients with claudication in the United
Kingdom, and this was the standard against which we
wished to assess our two exercise modalities.
Upper-limb exercise induces a greater cardiovas-
cular stress (greater heart rate, intra-arterial blood
pressure, and pulmonary ventilation) for a given level
of submaximal work than lower-limb exercise.7-11
Thus, the incremental upper-limb assessment was
necessary as a means of defining training intensity for
the upper-limb training group, and the lower-limb
assessment was used as a means of prescribing training
intensity for the lower-limb training group. The
penultimate workload achieved in the respective
assessment was used as the initial training intensity,
because this strategy enabled a similar cardiovascular
stress to be applied to each patient during the training
period. By using the penultimate load, we ensured
that the patients were working near to cardiac capaci-
ty, but only for short intervals during the training ses-
sions. For each of the supervised training sessions,
patients trained against this load in cycles of 2 minutes
of exercise, followed by 2 minutes of rest, for a total
exercise time of 20 minutes in a 40-minute session.
Interval training regimens such as this in healthy
patients enable a greater amount of higher-intensity
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work to be performed in a given time than could be
achieved with continuous exercise of a similar nature7
and, therefore, optimizes the stimulus for cardiovas-
cular adaptations. The MAP or MLP workloads iden-
tified during the initial assessment were applied after
3 weeks of training to ensure a sufficient stimulus for
continued improvement in cardiovascular fitness.
The maximum power achieved by the arms and
legs and the walking distances were determined imme-
diately after the training program was completed.
Quality of life assessment. All patients were
assessed at the beginning and end of the study peri-
od with the SF36 (Medical Outcomes Study) ques-
tionnaire.12
Statistical analysis. Data are presented as medi-
ans and first and third quartiles (Q25 and Q75). The
level of statistical significance was set at a P value of
.05. Data typically displayed skewness, and compar-
isons of variables between groups were performed
with the Wilcoxon signed rank test for paired data.
Categorical variables were compared with the χ2 and
Kruskal-Wallis tests. Patients dropping out of the
trial were included in the baseline comparisons to
test for differences between groups. They were not
entered into the analysis of the effects of training
because of the paired techniques used.
RESULTS
Patient attendance and compliance. Of the 67
patients recruited into this study, two patients
dropped out of each of the upper- and lower-limb
training groups. Shingles developed in one patient,
and another patient was unable to arrange trans-
portation. A third patient had chronic depression and
did not continue because of anxiety about the train-
ing, and a fourth patient dropped out for unknown
reasons. Attendance at the pretraining and posttrain-
ing assessments was 100% for all three groups, and
attendance at the training sessions was 98% for the
upper-limb group and 94% for the lower-limb group.
Pretraining characteristics of control and
patient groups. Before training, the MAP of the
patients was 20 W (range, 15 to 35 W), and the
MLP of the patients was 75 W (range, 50 to 100
W). The median CD and MWD of the patients was
142 m (range, 101 to 212 m) and 170 m (range,
120 to 301 m), respectively. Details of the CD and
MWD for the individual groups are shown in Table
I. The pretraining power outputs and walking dis-
tances of the three groups were not different.
Posttraining cardiovascular characteristics
Upper-limb ergometry assessments. The MAP
increased in all 24 patients who completed upper-
limb training, whereas the MAP of only 19 of the 24
patients in the lower-limb training group improved
(Fig 1). Overall, the improvements in both groups
were statistically significant (P < .001; Fig 1). No sig-
nificant change occurred in the untrained group, as a
whole.
Lower-limb ergometry assessments. Nineteen
of the 24 patients in the upper-limb training group
and 20 of the 24 patients in the lower-limb training
group improved their maximum achieved power
output in the lower-limb assessment. These improve-
ments were of statistical significance for both groups
(P < .001; Fig 2). No significant improvements were
Fig 1. Effects of upper- and lower-limb exercise training
on the maximum achieved arm power of individual
patients (upper) and the group as a whole (lower). Data are
presented as medians and 25th and 75th quartiles. *P <
.001 vs pre-training, Wilcoxon signed rank test.
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observed in the untrained group (P = 1.0). Upper-
limb training improved lower-limb performance in
this assessment.
Heart rate response to exercise. The heart rate
response to submaximal work loads during the upper-
and lower-limb assessments was reduced after train-
ing, confirming an improvement in the cardiovascular
system after both modes of exercise training (Fig 3).
Posttraining walking distances. The CD
(pain-free walking distance) increased by 122% in
the upper-limb training group (P < .001) and 93% in
the lower-limb (P < .001) training group (Fig 4).
The MWD increased by 47% in the upper-limb
group (P = .003) and 50% in the lower-limb group
(P < .001; Fig 5). The improvements in the claudi-
cation and MWDs observed in the upper- and lower-
limb groups were not significantly different from
each other (Mann-Whitney U test). No change in
either of these parameters occurred in the untrained
group (Figs 4, 5).
Quality of life. The “effect size” for each of the
eight domains assessed in the SF36 questionnaire
was calculated. This was achieved by dividing the
difference between the pretreatment and posttreat-
ment values by the interquartile range of the pre-
treatment value.12 The effect size is of value in
demonstrating the importance of a treatment effect
within a study.
Fig 2. Effects of upper- and lower-limb exercise training
on the maximum achieved leg power of individual patients
(upper) and the group as a whole (lower). Data are pre-
sented as medians and 25th and 75th quartiles. *P < .001
vs pre-training, Wilcoxon signed rank test.
Fig 3. Heart rates at a given work rate for the upper-limb
(upper) and lower-limb (lower) assessments before (dia-
mond) and after (square) exercise training. Data are medi-
an values for the given group. Zero power reflects the
internal resistance of the arm and leg ergometers.
Statistical differences between the groups are indicated
(Wilcoxon signed rank test).
Untrained
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The “physical functioning” and “role limitation-
physical” domains improved significantly after
upper-limb and lower-limb training (Fig 6). No sig-
nificant change in the other domains occurred. No
significant changes in any of the quality of life
domains occurred in the untrained group (Fig 6).
DISCUSSION
Exercise is well established as a treatment modali-
ty in patients with claudication, although the mecha-
nisms by which walking performance improves are
not well understood twice a day. This study demon-
strates that training twice a week in a 6-week period
significantly increases the walking distance of patients
with intermittent claudication. This program is con-
siderably shorter than the three-times-weekly proto-
cols for 6 months that have been recommended pre-
viously.1,3 Our findings suggest that training regi-
mens based on short, higher-intensity work with
interpolated rest periods are more efficient at produc-
ing rapid, symptomatic improvement. This may be
because of the increased cardiovascular stress, which
provides a better stimulus for exercise-induced adap-
tations. None of our patients reported any adverse
effects from this training system, although 53.9% of
patients in the leg training group experienced calf
pain, which required a reduction in the load applied,
during the later stages of exercise sessions.
Unfortunately, the availability of exercise pro-
grams in the United Kingdom is limited. Additional
problems occur with achieving high attendance
rates, because a large proportion of patients are
Fig 4. Effects of upper and lower limb exercise training on
pain-free (claudication) distance in individuals (upper) and
the group as a whole (lower). Data are medians and 25th and
75th quartiles. *P < .001 vs pretraining, Wilcoxon signed
rank test.
Fig 5. Effects of upper and lower limb exercise training on
maximum walking distances in individuals (upper) and the
group as a whole (lower). Data are medians and 25th and
75th quartiles. *P < .001 vs pretraining, Wilcoxon signed
rank test.
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unable to manage two to three sessions per week for
prolonged periods.4,13,14 The excellent attendance
and low dropout rate experienced in the present
study was partly due to the comparatively short
training program. Other contributory factors were
group training sessions, a flexible approach to the
time and day that each patient could attend, and the
provision of regular advice and encouragement.
The most important finding of this study is that
both upper- and lower-limb exercise training elicits
similar symptomatic improvements in patients with
claudication. These symptomatic changes were accom-
panied by significant improvements in the “physical
functioning” and “role limitation–physical” domains
of the SF36 questionnaire in both training groups.
This is in keeping with other studies, in which
improvements in these domains after exercise training
in patients with claudication were reported.15
However, in contrast to another study,16 we found no
improvements in the “bodily pain” domain. This may
occur because exercise training delays the onset of,
rather than eliminates, claudication pain. Furthermore,
our results provide an insight into the mechanisms by
which cardiovascular exercise training may be benefi-
cial, because they suggest that central cardiovascular
adaptations may be a factor in the increased walking
distances observed in the upper-limb training group.
Increasing the walking distance of patients with
intermittent claudication with exercise training pro-
grams has been described previously.1,3,5,17 The
physical discomfort encountered by performing
lower-limb weight-bearing exercise is undoubtedly a
major reason why this strategy has failed to achieve
widespread popularity. The prescription of a pain-
free upper-limb program may provide symptomatic
relief to a large number of patients with intermittent
claudication.
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